The DOI matches its Crossref record; 203 of the 203 references it cites were found in a registry or an index.
Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
Open accessAbstract
In the golden age of pharmaceutical nanocarriers, we are witnessing a maturation stage of the original concepts and ideas. There is no doubt that nanoformulations are extremely valuable tools for drug delivery applications; the current challenge is how to optimize them to ensure that they are safe, effective and scalable, so that they can be manufactured at an industrial level and advance to clinical use. In this context, lipid nanoparticles have gained ground, since they are generally regarded as non-toxic, biocompatible and easy-to-produce formulations. Pharmaceutical applications of lipid nanocarriers are a burgeoning field for the transport and delivery of a diversity of therapeutic agents, from biotechnological products to small drug molecules. This review starts with a brief overview of the characteristics of solid lipid nanoparticles and discusses the relevancy of performing systematic preformulation studies. The main applications, as well as the advantages that this type of nanovehicles offers in certain therapeutic scenarios are discussed. Next, pharmacokinetic aspects are described, such as routes of administration, absorption after oral administration, distribution in the organism (including brain penetration) and elimination processes. Safety and toxicity issues are also addressed. Our work presents an original point of view, addressing the biopharmaceutical aspects of these nanovehicles by means of descriptive statistics of the state-of-the-art of solid lipid nanoparticles research. All the presented results, trends, graphs and discussions are based in a systematic (and reproducible) bibliographic search that considered only original papers in the subject, covering a 7 years range (2013-today), a period that accounts for more than 60% of the total number of publications in the topic in the main bibliographic databases and search engines. Focus was placed on the therapeutic fields of application, absorption and distribution processes and current efforts for the translation into the clinical practice of lipid-based nanoparticles. For this, the currently active clinical trials on lipid nanoparticles were reviewed, with a brief discussion on what achievements or milestones are still to be reached, as a way of understanding the reasons for the scarce number of solid lipid nanoparticles undergoing clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Permana, A. D., Tekko, I. A., McCrudden, M. T. C., Anjani, Q. K., Ramadon, D., McCarthy, H. O., & Donnelly, R. F. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.10.004 · Cited by 213
RetractedPotent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
DrugBank 5.0: a major update to the DrugBank database for 2018
Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1037 · Cited by 8,404
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Bioavailability of curcumin: Problems and promises
Anand, P., Kunnumakkara, A. B., Newman, R. A., & Aggarwal, B. B. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700113r · Cited by 5,543
Danaei, M., Dehghankhold, M., Ataei, S., Hasanzadeh Davarani, F., Javanmard, R., Dokhani, A., Khorasani, S., & Mozafari, M. R. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10020057 · Cited by 4,832
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Design and Analysis of Experiments
Dean, A., Voss, D., & Draguljić, D. (2017) · Springer Texts in Statistics · doi:10.1007/978-3-319-52250-0 · Cited by 2,891
Sahay, G., Alakhova, D. Y., & Kabanov, A. V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.036 · Cited by 2,181
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00118-7 · Cited by 2,113
Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
Gupta, S. C., Patchva, S., & Aggarwal, B. B. (2013) · The AAPS Journal · doi:10.1208/s12248-012-9432-8 · Cited by 2,110
Rational siRNA design for RNA interference
Reynolds, A., Leake, D., Boese, Q., Scaringe, S., Marshall, W. S., & Khvorova, A. (2004) · Nature Biotechnology · doi:10.1038/nbt936 · Cited by 2,094
Klinge, U., Park, J.-K., & Klosterhalfen, B. (2013) · Pathobiology · doi:10.1159/000348446 · Cited by 1,783
Saraiva, C., Praça, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.044 · Cited by 1,609
Remington: The science and practice of pharmacy
(1996) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(96)90065-6 · Cited by 1,433
Gene silencing in mammals by small interfering RNAs
McManus, M. T., & Sharp, P. A. (2002) · Nature Reviews Genetics · doi:10.1038/nrg908 · Cited by 1,399
Nanostructured lipid matrices for improved microencapsulation of drugs
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00180-1 · Cited by 1,226
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective
Hare, J. I., Lammers, T., Ashford, M. B., Puri, S., Storm, G., & Barry, S. T. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.025 · Cited by 1,214
Lipid Nanoparticle Systems for Enabling Gene Therapies
Cullis, P. R., & Hope, M. J. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.013 · Cited by 1,208
Cellular Uptake, Intracellular Trafficking, and Cytotoxicity of Nanomaterials
Zhao, F., Zhao, Y., Liu, Y., Chang, X., Chen, C., & Zhao, Y. (2011) · Small · doi:10.1002/smll.201100001 · Cited by 1,175
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
Kowalski, P. S., Rudra, A., Miao, L., & Anderson, D. G. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.02.012 · Cited by 1,127
Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
Puri, A., Loomis, K., Smith, B., Lee, J.-H., Yavlovich, A., Heldman, E., & Blumenthal, R. (2009) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v26.i6.10 · Cited by 1,069
Xiao, K., Li, Y., Luo, J., Lee, J. S., Xiao, W., Gonik, A. M., Agarwal, R. G., & Lam, K. S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.021 · Cited by 1,039
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.006 · Cited by 956
Phagocytosis: An Immunobiologic Process
Gordon, S. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.026 · Cited by 902 · cited 1×
“Internalized nonbiodegradable materials may however exert several cytotoxic effects, contributing to chronic inflammation and progressive tissue injury (Gordon, 2016; Azarnezhad et al., 2020).”
BackgroundPelaz, B., del Pino, P., Maffre, P., Hartmann, R., Gallego, M., Rivera-Fernández, S., de la Fuente, J. M., Nienhaus, G. U., & Parak, W. J. (2015) · ACS Nano · doi:10.1021/acsnano.5b01326 · Cited by 890
Knocking down disease: a progress report on siRNA therapeutics
Wittrup, A., & Lieberman, J. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3978 · Cited by 804
Antimicrobial Resistance in Bacteria: Mechanisms, Evolution, and Persistence
Christaki, E., Marcou, M., & Tofarides, A. (2020) · Journal of Molecular Evolution · doi:10.1007/s00239-019-09914-3 · Cited by 780
The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery
Cheng, X., & Lee, R. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.01.022 · Cited by 703
Nanomaterial-based blood-brain-barrier (BBB) crossing strategies
Xie, J., Shen, Z., Anraku, Y., Kataoka, K., & Chen, X. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119491 · Cited by 604
Lipid nanoparticles enabling gene therapies: from concepts to clinical utility
Kulkarni, J. A., Cullis, P. R., & van der Meel, R. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0721 · Cited by 592
Schwarz, C., Mehnert, W., Lucks, J. S., & Müller, R. H. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90047-7 · Cited by 574
Gordillo-Galeano, A., & Mora-Huertas, C. E. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.10.017 · Cited by 569
Phagocytosis: A Fundamental Process in Immunity
Rosales, C., & Uribe-Querol, E. (2017) · BioMed Research International · doi:10.1155/2017/9042851 · Cited by 552
Brain Endothelial Cell-Cell Junctions: How to “Open” the Blood Brain Barrier
Stamatovic, S., Keep, R., & Andjelkovic, A. (2008) · Current Neuropharmacology · doi:10.2174/157015908785777210 · Cited by 513
More Effective Nanomedicines through Particle Design
Wang, J., Byrne, J. D., Napier, M. E., & DeSimone, J. M. (2011) · Small · doi:10.1002/smll.201100442 · Cited by 466
Zensi, A., Begley, D., Pontikis, C., Legros, C., Mihoreanu, L., Wagner, S., Büchel, C., von Briesen, H., & Kreuter, J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.03.002 · Cited by 438
Degradability and Clearance of Inorganic Nanoparticles for Biomedical Applications
Yang, G., Phua, S. Z. F., Bindra, A. K., & Zhao, Y. (2019) · Advanced Materials · doi:10.1002/adma.201805730 · Cited by 436
50 years of oral lipid-based formulations: provenance, progress and future perspectives
Feeney, O. M., Crum, M. F., McEvoy, C. L., Trevaskis, N. L., Williams, H. D., Pouton, C. W., Charman, W. N., Bergström, C. A. S., & Porter, C. J. H. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.007 · Cited by 426
Fang, C., Shi, B., Pei, Y.-Y., Hong, M.-H., Wu, J., & Chen, H.-Z. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.08.002 · Cited by 424
Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain
Pardridge, W. M. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00373 · Cited by 405
Effect of Adsorbed Proteins on the Wettability of Hydrophilic and Hydrophobic Solids
VROMAN, L. (1962) · Nature · doi:10.1038/196476a0 · Cited by 403
Martins, S., Sarmento, B. F. C. C., Ferreira, D., & Souto, E. B. (2007) · PubMed Central · Cited by 399
Geszke-Moritz, M., & Moritz, M. (2016) · Materials Science and Engineering: C · doi:10.1016/j.msec.2016.05.119 · Cited by 392
Cleavable PEGylation: a strategy for overcoming the “PEG dilemma” in efficient drug delivery
Fang, Y., Xue, J., Gao, S., Lu, A., Yang, D., Jiang, H., He, Y., & Shi, K. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1388451 · Cited by 386
Bridging Bio–Nano Science and Cancer Nanomedicine
Björnmalm, M., Thurecht, K. J., Michael, M., Scott, A. M., & Caruso, F. (2017) · ACS Nano · doi:10.1021/acsnano.7b04855 · Cited by 382
Lipid-based formulations for intestinal lymphatic delivery
O’Driscoll, C. M. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00051-9 · Cited by 372
Gessner, A., Lieske, A., Paulke, B. R., & Müller, R. H. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00081-4 · Cited by 356
Ma, Z., Wang, N., He, H., & Tang, X. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.10.053 · Cited by 345
Benet, L. Z. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23359 · Cited by 342
Luo, Y., Teng, Z., Li, Y., & Wang, Q. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2014.12.084 · Cited by 332
Breaking Down the Barriers to Precision Cancer Nanomedicine
von Roemeling, C., Jiang, W., Chan, C. K., Weissman, I. L., & Kim, B. Y. S. (2017) · Trends in Biotechnology · doi:10.1016/j.tibtech.2016.07.006 · Cited by 330
Towards clinically translatable in vivo nanodiagnostics
Park, S.-M., Aalipour, A., Vermesh, O., Yu, J. H., & Gambhir, S. S. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.14 · Cited by 327
Maisel, K., Ensign, L., Reddy, M., Cone, R., & Hanes, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.026 · Cited by 319
Schneider, C. S., Xu, Q., Boylan, N. J., Chisholm, J., Tang, B. C., Schuster, B. S., Henning, A., Ensign, L. M., Lee, E., Adstamongkonkul, P., et al. (2017) · Science Advances · doi:10.1126/sciadv.1601556 · Cited by 311
Transcytosis at the blood–brain barrier
Ayloo, S., & Gu, C. (2019) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2018.12.014 · Cited by 296
Doktorovová, S., Kovačević, A. B., Garcia, M. L., & Souto, E. B. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.08.001 · Cited by 293
Understanding the Lipid and Protein Corona Formation on Different Sized Polymeric Nanoparticles
Lima, T., Bernfur, K., Vilanova, M., & Cedervall, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-57943-6 · Cited by 250
An Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development
Wang, F., Kream, R. M., & Stefano, G. B. (2020) · Medical Science Monitor · doi:10.12659/msm.924700 · Cited by 243
Neves, A. R., Queiroz, J. F., & Reis, S. (2016) · Journal of Nanobiotechnology · doi:10.1186/s12951-016-0177-x · Cited by 240
Yuan, H., Chen, C.-Y., Chai, G.-H., Du, Y.-Z., & Hu, F.-Q. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300649z · Cited by 234
Ceña, V., & Játiva, P. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0139 · Cited by 232
An RNA toolbox for cancer immunotherapy
Pastor, F., Berraondo, P., Etxeberria, I., Frederick, J., Sahin, U., Gilboa, E., & Melero, I. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.132 · Cited by 229
Kakkar, V., Muppu, S. K., Chopra, K., & Kaur, I. P. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.02.005 · Cited by 222
Müller, R., Maaben, S., Weyhers, H., & Mehnert, W. (1996) · Journal of Drug Targeting · doi:10.3109/10611869609015973 · Cited by 222
Intestinal lymphatic vasculature: structure, mechanisms and functions
Bernier-Latmani, J., & Petrova, T. V. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.79 · Cited by 219
Translation of rabbit globin mRNA introduced by liposomes into mouse lymphocytes
DIMITRIADIS, G. J. (1978) · Nature · doi:10.1038/274923a0 · Cited by 212
Nafee, N., Husari, A., Maurer, C. K., Lu, C., de Rossi, C., Steinbach, A., Hartmann, R. W., Lehr, C.-M., & Schneider, M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.055 · Cited by 208
Future cancer research priorities in the USA: a Lancet Oncology Commission
Jaffee, E. M., Dang, C. V., Agus, D. B., Alexander, B. M., Anderson, K. C., Ashworth, A., Barker, A. D., Bastani, R., Bhatia, S., Bluestone, J. A., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30698-8 · Cited by 208
Ramalingam, P., & Ko, Y. T. (2015) · Pharmaceutical Research · doi:10.1007/s11095-014-1469-1 · Cited by 206
Baek, J.-S., & Cho, C.-W. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.04.013 · Cited by 204
Sadegh Malvajerd, S., Azadi, A., Izadi, Z., Kurd, M., Dara, T., Dibaei, M., Sharif Zadeh, M., Akbari Javar, H., & Hamidi, M. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00510 · Cited by 202
Kushwaha, A. K., Vuddanda, P. R., Karunanidhi, P., Singh, S. K., & Singh, S. (2013) · BioMed Research International · doi:10.1155/2013/584549 · Cited by 201
Curcumin: Recent Advances in the Development of Strategies to Improve Oral Bioavailability
Sanidad, K. Z., Sukamtoh, E., Xiao, H., McClements, D. J., & Zhang, G. (2019) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-032818-121738 · Cited by 190
Keck, C. M., & Müller, R. H. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.01.001 · Cited by 178
Adams, D., Suhr, O. B., Dyck, P. J., Litchy, W. J., Leahy, R. G., Chen, J., Gollob, J., & Coelho, T. (2017) · BMC Neurology · doi:10.1186/s12883-017-0948-5 · Cited by 178
Vaghasiya, H., Kumar, A., & Sawant, K. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.03.013 · Cited by 173
Gupta, S., Kesarla, R., Chotai, N., Misra, A., & Omri, A. (2017) · BioMed Research International · doi:10.1155/2017/5984014 · Cited by 172
Senthil Kumar, C., Thangam, R., Mary, S. A., Kannan, P. R., Arun, G., & Madhan, B. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.115682 · Cited by 168
Talegaonkar, S., & Bhattacharyya, A. (2019) · AAPS PharmSciTech · doi:10.1208/s12249-019-1337-8 · Cited by 165
Understanding the Chemical Nature of Nanoparticle–Protein Interactions
Baimanov, D., Cai, R., & Chen, C. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00348 · Cited by 165
Rosière, R., Van Woensel, M., Gelbcke, M., Mathieu, V., Hecq, J., Mathivet, T., Vermeersch, M., Van Antwerpen, P., Amighi, K., & Wauthoz, N. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00846 · Cited by 161
Shi, S., Han, L., Deng, L., Zhang, Y., Shen, H., Gong, T., Zhang, Z., & Sun, X. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.09.005 · Cited by 158
Solid lipid nanoparticles for enhanced oral absorption: A review
Salah, E., Abouelfetouh, M. M., Pan, Y., Chen, D., & Xie, S. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.111305 · Cited by 157
Cancer nanomedicines: oversold or underappreciated?
van der Meel, R., Lammers, T., & Hennink, W. E. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2017.1262346 · Cited by 156
Biodegradation of solid lipid nanoparticles as a function of lipase incubation time
Müller, R. H., Rühl, D., & Runge, S. (1996) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(96)04731-x · Cited by 155
Gupta, R. K., Dwadasi, B. S., Rai, B., & Mitragotri, S. (2019) · Scientific Reports · doi:10.1038/s41598-018-37900-0 · Cited by 154
Chetoni, P., Burgalassi, S., Monti, D., Tampucci, S., Tullio, V. C., Cuffini, A., Muntoni, E., Spagnolo, R., Zara, G. P., & Cavalli, R. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.006 · Cited by 153
Youssef, N. A. H. A., Kassem, A. A., Farid, R. M., Ismail, F. A., EL-Massik, M. A. E., & Boraie, N. A. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.07.014 · Cited by 153
Is nanotechnology a boon for oral drug delivery?
Agrawal, U., Sharma, R. K., Gupta, M., & Vyas, S. P. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.04.011 · Cited by 150
Mannose-functionalized solid lipid nanoparticles are effective in targeting alveolar macrophages
Costa, A., Sarmento, B. F. C. C., & Seabra, V. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.12.006 · Cited by 150
Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN)
Göppert, T. M., & MULLER, R. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.02.006 · Cited by 145
Oral delivery of siRNA lipid nanoparticles: Fate in the GI tract
Ball, R. L., Bajaj, P., & Whitehead, K. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-20632-6 · Cited by 145
Novel Solid Lipid Nanoparticle with Endosomal Escape Function for Oral Delivery of Insulin
Xu, Y., Zheng, Y., Wu, L., Zhu, X., Zhang, Z., & Huang, Y. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b00507 · Cited by 143
Physical Chemical Considerations of Lipid-Based Oral Drug Delivery-Solid Lipid Nanoparticles
Bummer, P. M. (2004) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v21.i1.10 · Cited by 137
Gaspar, D. P., Faria, V., Gonçalves, L., Taboada, P., Remuñán‐López, C., & Almeida, A. J. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.11.050 · Cited by 136
Zhang, J., Zhu, X. D., Jin, Y., Shan, W., & Huang, Y. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400685v · Cited by 136
Kadari, A., Pooja, D., Ravuri, H. G., Gudem, S., KOLAPALLI, V. R. M., Kulhari, H., & Sistla, R. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.09.012 · Cited by 124
Zheng, G., Zheng, M., Yang, B., Fu, H., & Li, Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109006 · Cited by 124
Neves, A. R., Queiroz, J. F., Weksler, B., Romero, I. A., Couraud, P.-O., & Reis, S. (2015) · Nanotechnology · doi:10.1088/0957-4484/26/49/495103 · Cited by 122
Evidence does not support absorption of intact solid lipid nanoparticles via oral delivery
Hu, X., Fan, W., Yu, Z., Lü, Y., Qi, J., Zhang, J., Dong, X., Zhao, W., & Wu, W. (2015) · Nanoscale · doi:10.1039/c5nr07474f · Cited by 120
Neves, A. R., Queiroz, J. F., Lima, S. A. C., & Reis, S. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00705 · Cited by 120
Kovačević, A. B., Müller, R. H., Savic, S. D., Vuleta, G. M., & Keck, C. M. (2013) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2013.12.023 · Cited by 118
Patel, M., Souto, E. B., & Singh, K. K. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.784742 · Cited by 115
Montoto, S. S., Sbaraglini, M. L., Talevi, A., Couyoupetrou, M., Ianni, M., Pesce, G. O., Álvarez, V. A., Bruno‐Blanch, L. E., Castro, G. R., Ruiz, M. E., et al. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.03.052 · Cited by 115
Self-citation5-Fluorouracil shell-enriched solid lipid nanoparticles (SLN) for effective skin carcinoma treatment
Khallaf, R. A., Salem, H. F., & Abdelbary, A. (2016) · Drug Delivery · doi:10.1080/10717544.2016.1194498 · Cited by 114
Enhanced stability and dermal delivery of hydroquinone using solid lipid nanoparticles
Ghanbarzadeh, S., Hariri, R., Kouhsoltani, M., Shokri, J., Javadzadeh, Y., & Hamishehkar, H. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.10.041 · Cited by 113
Amasya, G., Aksu, B., Badıllı, U., Onay-Beşikçi, A., & Tarımcı, N. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.03.056 · Cited by 113
Fan, T., Chen, C., Guo, H., Xu, J., Zhang, J., Zhu, X. D., Yang, Y., Zhou, Z., Li, L., & Huang, Y. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.06.011 · Cited by 112
Kang, J., Chon, J., Kim, Y., Lee, H., Oh, D., Lee, H.-G., Han, C.-S., Kim, D., & Park, C. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s215153 · Cited by 108
Rajpoot, K., & Jain, S. K. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1366338 · Cited by 107
Rajpoot, K., & Jain, S. K. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.02.132 · Cited by 104
Hosseini, S. M., Abbasalipourkabir, R., Jalilian, F. A., Asl, S. S., Farmany, A., Roshanaei, G., & Arabestani, M. R. (2019) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-019-0504-8 · Cited by 103
Dermal delivery of doxorubicin-loaded solid lipid nanoparticles for the treatment of skin cancer
Tupal, A., Sabzichi, M., Ramezani, F., Kouhsoltani, M., & Hamishehkar, H. (2016) · Journal of Microencapsulation · doi:10.1080/02652048.2016.1200150 · Cited by 101
Sesamol-loaded solid lipid nanoparticles for treatment of skin cancer
Geetha, T., Kapila, M., Prakash, O., Deol, P. K., Kakkar, V., & Kaur, I. P. (2014) · Journal of drug targeting · doi:10.3109/1061186x.2014.965717 · Cited by 97
Vijayakumar, A., Baskaran, R., Jang, Y. S., Oh, S. H., & Yoo, B. K. (2016) · AAPS PharmSciTech · doi:10.1208/s12249-016-0573-4 · Cited by 97
Pandya, N., Jani, P., Vanza, J. D., & Tandel, H. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.02.011 · Cited by 94
Ahmad, I. N., Pandit, J., Sultana, Y., Mishra, A. K., Hazari, P. P., & Aqil, M. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.03.060 · Cited by 94
Mannosylated solid lipid nanoparticles for the selective delivery of rifampicin to macrophages
Vieira, A. C. C., Chaves, L. L., Pinheiro, M., Lima, S. A. C., Ferreira, D., Sarmento, B. F. C. C., & Reis, S. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1434186 · Cited by 92
Stealth coatings for nanoparticles
Hadjesfandiari, N., & Anilkumar, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-101750-0.00013-1 · Cited by 90
Mohanty, B., MAJUMDAR, D. K., Mishra, S. K., Panda, A. K., & Patnaik, S. (2014) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2014.882935 · Cited by 89
Krishna, K. V., Wadhwa, G., Alexander, A., Kanojia, N., Saha, R. N., Kukreti, R., Singhvi, G., & Dubey, S. K. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00343 · Cited by 89
Microparticles Used as Drug Delivery Systems
Siepmann, J., & Siepmann, F. (2006) · Springer eBooks · doi:10.1007/3-540-32702-9_3 · Cited by 87
Yu, S.-H., Tang, D.-W., Hsieh, H., Wu, W.-S., Lin, B.-X., Chuang, E., Sung, H., & Mi, F. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.04.009 · Cited by 86
Azarnezhad, A., Samadian, H., Jaymand, M., Sobhani, M., & Ahmadi, A. (2020) · Critical Reviews in Toxicology · doi:10.1080/10408444.2020.1719974 · Cited by 85
Keck, C. M., Kovačević, A. B., Müller, R. H., Savic, S. D., Vuleta, G. M., & Milić, J. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.08.008 · Cited by 83
Plasma Protein Adsorption of Tween 80- and Poloxamer 188-stabilized Solid Lipid Nanoparticles
Göppert, T. M., & Müller, R. H. (2003) · Journal of drug targeting · doi:10.1080/10611860310001615956 · Cited by 81
Chirio, D., Peira, E., Dianzani, C., Muntoni, E., Gigliotti, C. L., Ferrara, B., Sapino, S., Chindamo, G., & Gallarate, M. (2019) · Nanomaterials · doi:10.3390/nano9020230 · Cited by 80
Severino, P., Chaud, M. V., Shimojo, A., Antonini, D., Lancelloti, M., Santana, M. H. A., & Souto, E. B. (2015) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2015.03.049 · Cited by 77
Kong, W. H., Park, K., Lee, M. Y., Lee, H., Sung, D. K., & Hahn, S. K. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.067 · Cited by 77
Microencapsulated Solid Lipid Nanoparticles as a Hybrid Platform for Pulmonary Antibiotic Delivery
Gaspar, D. P., Gaspar, M. M., Eleutério, C., Grenha, A., Blanco, M., Gonçalves, L., Taboada, P., Almeida, A. J., & Remuñán‐López, C. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00169 · Cited by 77
Beguin, P., Errachid, A., Larondelle, Y., & Schneider, Y. (2013) · Food & Function · doi:10.1039/c3fo60036j · Cited by 76
Hady, M. A., Sayed, O. M., & Akl, M. A. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.111076 · Cited by 75
Chen, C., Fan, T., Jin, Y., Zhou, Z., Yang, Y., Zhu, X. D., Zhang, Z., Zhang, Q., & Huang, Y. (2012) · Nanomedicine · doi:10.2217/nnm.12.141 · Cited by 72
Rodenak‐Kladniew, B., Montoto, S. S., Sbaraglini, M. L., Ianni, M., Ruiz, M. E., Talevi, A., Álvarez, V. A., Durán, N., Castro, G. R., & Islan, G. A. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118575 · Cited by 72
Self-citationJoshy, K. S., Sharma, C. P., Kalarikkal, N., Sandeep., K., Thomas, S., & Pothen, L. A. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.03.031 · Cited by 71
Chai, G., Hu, F., Sun, J., Du, Y., You, J., & Yuan, H. (2014) · Molecular Pharmaceutics · doi:10.1021/mp5004674 · Cited by 69
Holm, J., & Hansen, S. I. (2020) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2020.140466 · Cited by 66
Ahmadnia, S., Moazeni, M., Mohammadi‐Samani, S., & Oryan, A. (2013) · Experimental Parasitology · doi:10.1016/j.exppara.2013.07.017 · Cited by 65
Maretti, E., Costantino, L., Rustichelli, C., Leo, E., Croce, M. A., Buttini, F., Truzzi, E., & Iannuccelli, V. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.06.045 · Cited by 65
Transport of stearic acid-based solid lipid nanoparticles (SLNs) into human epithelial cells
Shah, R., Rajasekaran, D., Ludford‐Menting, M., Eldridge, D. S., Palombo, E. A., & Harding, I. H. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.12.029 · Cited by 64
Solid lipid nanoparticle: an efficient carrier for improved ocular permeation of voriconazole
Kumar, R., & Sinha, V. R. (2016) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2016.1185437 · Cited by 64
Evading P-glycoprotein mediated-efflux chemoresistance using Solid Lipid Nanoparticles
Cavaco, M. C., Pereira, C. A., Kreutzer, B., Gouveia, L. F., Lima, B. S., Brito, M. A., & Videira, M. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.024 · Cited by 64
Talluri, S. V., Pindiprolu, S. K. S. S., Chintamaneni, P. K., Tummala, S., & Kumar, S. N. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1313267 · Cited by 64
Hamishehkar, H., Ghanbarzadeh, S., Sepehran, S., Javadzadeh, Y., Adib, Z. M., & Kouhsoltani, M. (2015) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2015.1062896 · Cited by 62
Haque, S., Whittaker, M. R., McIntosh, M. P., Pouton, C. W., Phipps, S., & Kaminskas, L. M. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.01.001 · Cited by 62
Solid lipid nanoparticles for the delivery of anti-microbial oligonucleotides
González-Paredes, A., Sitia, L., Ruyra, À., Morris, C. J., Wheeler, G. N., McArthur, M., & Gasco, P. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.11.017 · Cited by 62
Doktorovová, S., Souto, E. B., & Silva, A. M. (2017) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2017.1384491 · Cited by 61
Küçüktürkmen, B., & Bozkır, A. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1391835 · Cited by 60
Li, Y., Wu, M., Zhang, N., Tang, C., Jiang, P., Liu, X., Yan, F., & Zheng, H. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13695 · Cited by 60
Souto, E. B., Doktorovová, S., Campos, J. R. S., Martins‐Lopes, P., & Silva, A. M. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.11.022 · Cited by 60
Patel, M., Mundada, V. P., & Sawant, K. K. (2019) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2019.1593434 · Cited by 60
McCartney, F., Rosa, M., & Brayden, D. J. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11110565 · Cited by 57
Tran, T. H., Ramasamy, T., Cho, H. J., Kim, Y. I., Poudel, B. K., Choi, H., Yong, C. S., & Kim, J. O. (2014) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2014.8722 · Cited by 56
In vivo fate of lipid-silybin conjugate nanoparticles: Implications on enhanced oral bioavailability
Ma, Y., He, H., Xia, F., Li, Y., Lu, Y., Chen, D., Qi, J., Lü, Y., Zhang, W., & Wu, W. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.07.014 · Cited by 55
Banerjee, S., Roy, S., Bhaumik, K. N., & Pillai, J. D. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1613409 · Cited by 53
Effect of Iontophoresis on Topical Delivery of Doxorubicin-Loaded Solid Lipid Nanoparticles
Taveira, S. F., de Santana, D. C. A. S., Araújo, L. M. P. D. C., Marquele‐Oliveira, F., Nomizo, A., & Lopez, R. F. V. (2014) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2014.1834 · Cited by 52
Ruiz, M. E., & Montoto, S. S. (2018) · Springer eBooks · doi:10.1007/978-3-319-99593-9_6 · Cited by 52
Self-citationImproved antibacterial function of Rifampicin-loaded solid lipid nanoparticles on Brucella abortus
Ghaderkhani, J., Yousefimashouf, R., Arabestani, M. R., Roshanaei, G., Asl, S. S., & Abbasalipourkabir, R. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1593858 · Cited by 52
Wang, L., Zhao, X. G., Du, J., Liu, M., Feng, J., & Hu, K. (2019) · Nanomedicine · doi:10.2217/nnm-2018-0417 · Cited by 52
Rehman, M. U., Khan, M. A., Khan, W. S., Shafique, M. S., & Khan, M. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1396996 · Cited by 51
Silki, & Sinha, V. R. (2018) · AAPS PharmSciTech · doi:10.1208/s12249-017-0944-5 · Cited by 50
Daneshmand, S., Jaafari, M. R., Movaffagh, J., Malaekeh‐Nikouei, B., Iranshahi, M., Moghaddam, A. S., Najaran, Z. T., & Golmohammadzadeh, S. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.01.054 · Cited by 50
Development and evaluation of insulin-loaded cationic solid lipid nanoparticles for oral delivery
Hecq, J., Amighi, K., & Goole, J. (2016) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2016.10.012 · Cited by 49
Effect of Surface Charges on Oral Absorption of Intact Solid Lipid Nanoparticles
Yu, Z., Fan, W., Wang, L., Qi, J., Lü, Y., & Wu, W. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00861 · Cited by 49
Solid Lipid Nanoparticles of Guggul Lipid as Drug Carrier for Transdermal Drug Delivery
Gaur, P. K., Mishra, S., & Purohit, S. (2013) · BioMed Research International · doi:10.1155/2013/750690 · Cited by 47
Kuo, Y., & Lee, C. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.01.025 · Cited by 47
Beg, S., Jain, S., Kushwah, V., Bhatti, G. K., Sandhu, P. S., Katare, O. P., & Singh, B. (2017) · Nanomedicine · doi:10.2217/nnm-2016-0336 · Cited by 47
Wu, X., Chen, H., Wu, C., Wang, J., Zhang, S., Gao, J., Wang, H., Sun, T., & Yang, Y. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.11.040 · Cited by 46
Biomaterial–tight junction interaction and potential impacts
Han, X., Zhang, E., Shi, Y., Song, B., Du, H., & Cao, Z. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb01081e · Cited by 45
Shah, R., Eldridge, D. S., Palombo, E. A., & Harding, I. H. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.10.054 · Cited by 44
Sathya, S., Shanmuganathan, B., Manirathinam, G., Kandasamy, R., & Devi, K. P. (2018) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2018.05.075 · Cited by 44
Rajpoot, K., & Jain, S. K. (2019) · Journal of Microencapsulation · doi:10.1080/02652048.2019.1665723 · Cited by 44
Nooli, M., Chella, N., Kulhari, H., Shastri, N. R., & Sistla, R. (2016) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2016.1275666 · Cited by 42
Talluri, S. V., Kuppusamy, G., Karri, V. V. S. R., Yamjala, K., Wadhwani, A. D., Madhunapantula, S. V., & Pindiprolu, S. K. S. S. (2016) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2016.1173046 · Cited by 40
Yao, M., McClements, D. J., Zhao, F.-Q., Craig, R. W., & Xiao, H. (2016) · NanoImpact · doi:10.1016/j.impact.2016.12.001 · Cited by 40
Microemulsion extrusion technique: a new method to produce lipid nanoparticles
de Jesus, M. B., Radaic, A., Zuhorn, I. S., & de Paula, E. (2013) · Journal of Nanoparticle Research · doi:10.1007/s11051-013-1960-3 · Cited by 39
Nakhlband, A., Eskandani, M., Saeedi, N., Ghafari, S., Omidi, Y., Barar, J., & Garjani, A. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.01.046 · Cited by 38
Kuo, Y., & Wang, C. (2013) · Biotechnology Progress · doi:10.1002/btpr.1834 · Cited by 37
Kotmakçı, M., Çetintaş, V. B., & Kantarcı, A. G. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.04.034 · Cited by 36
Mazuryk, J., Deptuła, T., Polchi, A., Gapiński, J., Giovagnoli, S., Magini, A., Emiliani, C., Kohlbrecher, J., & Patkowski, A. (2016) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2016.05.017 · Cited by 35
Rudhrabatla, V. S. A. P., Sudhakar, B., & Reddy, K. V. N. S. (2019) · BioNanoScience · doi:10.1007/s12668-019-00680-6 · Cited by 34
Crystalloids against colloids in the theory of cements
le Chatelier, H. (1919) · Transactions of the Faraday Society · doi:10.1039/tf9191400008 · Cited by 34
Veni, D. K., & Gupta, N. V. (2019) · International Journal of Polymeric Materials · doi:10.1080/00914037.2019.1570513 · Cited by 33
Abdrabou, A., Bharali, D. J., & Mousa, S. A. (2018) · Pharmaceutical Research · doi:10.1007/s11095-017-2283-3 · Cited by 31
Martínez-Jothar, L., Barendrecht, A. D., de Graaff, A. M., Oliveira, S., van Nostrum, C. F., Schiffelers, R. M., Hennink, W. E., & Fens, M. H. A. M. (2020) · Nanomaterials · doi:10.3390/nano10071353 · Cited by 31
Shi, L., Cao, Y. Z., Zhu, X.-Y., Cui, J.-H., & Cao, Q. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.11.017 · Cited by 29
Karn-orachai, K., Smith, S. M., Saesoo, S., Treethong, A., Puttipipatkhachorn, S., Pratontep, S., & Ruktanonchai, U. (2015) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2015.10.011 · Cited by 29
Chaves, L. L., Lima, S. A. C., Vieira, A. C. C., Ferreira, D., Sarmento, B. F. C. C., & Reis, S. (2018) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0932 · Cited by 28
He, Y., Zhan, C., Pi, C., Zuo, Y., Yang, S., Hu, M. L., Bai, Y. B., Zhao, L., & Wei, Y. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-020-01711-2 · Cited by 26
Cacicedo, M. L., Ruiz, M. C., Montoto, S. S., Ruiz, M. E., Fernandez, M. A., Torres-Sanchez, R. M., Baran, E. J., Castro, G. R., & León, I. E. (2019) · New Journal of Chemistry · doi:10.1039/c9nj01634a · Cited by 25
Self-citationJain, A. K., & Thareja, S. (2020) · Nanotechnology in the life sciences · doi:10.1007/978-3-030-34544-0_13 · Cited by 25
Ianni, M. E. D., Islan, G. A., Chain, C. Y., Castro, G. R., Talevi, A., & Vela, M. E. (2017) · Journal of Nanomaterials · doi:10.1155/2017/6509184 · Cited by 22
Bauer, T., Patel, M., Jimeno, A., Wang, D., McDermott, J., Zacharek, S., Randolph, W., Johansen, L., Hopson, K., Frederick, J., et al. (2019) · Cancer Research · doi:10.1158/1538-7445.am2019-ct210 · Cited by 15
Liu, J.-L., Li, J., Zhang, L.-Y., Zhang, P.-L., Zhou, J.-L., & Liu, B. (2017) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v16i8.3 · Cited by 15
Surface modified kokum butter lipid nanoparticles for the brain targeted delivery of nevirapine
Lahkar, S., & Das, M. K. (2018) · Journal of Microencapsulation · doi:10.1080/02652048.2019.1573857 · Cited by 14
Lipid nanocarriers for delivery of poorly soluble and poorly permeable drugs
Kovačević, A. B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817778-5.00008-7 · Cited by 11
Cited by
Tenchov, R., Bird, R., Curtze, A. E., & Zhou, Q. (2021) · ACS Nano · doi:10.1021/acsnano.1c04996 · Cited by 2,221
Controlled Drug Delivery Systems: Current Status and Future Directions
Adepu, S., & Ramakrishna, S. (2021) · Molecules · doi:10.3390/molecules26195905 · Cited by 1,691
Mehta, M., Bui, T. A., Yang, X., Aksoy, Y., Goldys, E. M., & Deng, W. (2023) · ACS Materials Au · doi:10.1021/acsmaterialsau.3c00032 · Cited by 688
Lipid Nanoparticles for Drug Delivery
Xu, L., Wang, X., Liu, Y., Yang, G., Falconer, R. J., & Zhao, C.-X. (2022) · Advanced NanoBiomed Research · doi:10.1002/anbr.202100109 · Cited by 545
Lipid Nanoparticles as Carriers for Bioactive Delivery
Dhiman, N., Awasthi, R., Sharma, B., Kharkwal, H., & Kulkarni, G. T. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.580118 · Cited by 345
Metadata
- Authors
- Scioli Montoto, S., Muraca, G., & Ruiz, M. E.
- Venue
- Frontiers in Molecular Biosciences
- Publisher
- Frontiers Media SA
- Published
- 2020-10-30
- Volume
- 7
- Pages
- 587997-587997
- ISSN
- 2296-889X (ISSN-L)
- OpenAlex
- W3095652295
- Cited by
- 652
- References
- 203
- FWCI
- 17.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.